Synthesis and Characterization of Valacyclovir HCl Hybrid Solid Lipid Nanoparticles by Using Natural Oils

Author(s): Archana Chacko, Amaldoss M.J. Newton*.

Journal Name: Recent Patents on Drug Delivery & Formulation

Volume 13 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: The Jojoba Simmondsia Chinensis oil is used as one of the main ingredients which has an antioxidant, moisturizing and stabilizing activity. Likewise, grape seed (Vitis vinifera) oil is also used in this preparation which also has some remarkable medicinal properties such as antioxidant, astringent and is also used as a moisturizer. The Valacyclovir Solid Lipid Nanoparticles (SLN) are prepared in combination.

Objective: The prime objective of the study was to prepare a nanodispersion with good stability indicating zeta potential. The formulations were prepared by varying concentrations of jojoba oil and grape seed oil which form the hybrid nanoparticles with the drug.

Methods: The high-pressure hot-homogenization technique was used to prepare the nanoparticles. The prepared nanoparticles were subjected to characterization analysis such as Mean particle size, Zaverage, and Zeta potential by using Dynamic Light Scattering (DLS) and Photon Correlation Spectroscopy (PCS). The best formulation was subjected to Transmission Electron Microscopy (TEM) technique for surface morphology and other characterizations. The crystalline pattern of the drug alone, drug-loaded nanoparticles and nanoparticles without the drug was studied by XRD. The drug excipients compatibility studies were performed by using Fourier-Transform Infrared Spectroscopy (FTIR) Differential Scanning Calorimetry and (DSC). The other factors such as in vitro drug release, and % drug entrapment efficiency were studied by using suitable methods.

Results: The results demonstrated that the particles are in nano range with good stability with appreciable Zeta potential (-48.2±mV). The selected formulations were analyzed for MPS which demonstrated the value of 306.7±183.4 and 416.5±289.3. The best formulation VNP5 demonstrated the Bellshaped curve and confirmed the uniform distribution.

Conclusion: Based on the patents, it was demonstrated that valacyclovir is widely used in the treatment and prophylaxis of viral infections in human, particularly infections caused by the herpes group of viruses. Valacyclovir is an effective drug for the treatment of cold sores.

Keywords: SLN, valacyclovir, zeta potential, TEM, XRD, DSC, FTIR.

[1]
Akanksha G, Deepti S, Navneet G. Solid Lipid Nanoparticles (SLN): Method, characterization, and applications. Int Curr Pharm J 2012; 1: 384-93.
[2]
Mohamad SSS. Nanomedicine and use of nanotechnology in drug delivery systems: A novel approach. Int J Res Pharm Biomed Sci 2011; 2(3): 926-9.
[3]
Robert AF. Current Status of Nanomedicine and Medical Nanorobotics. J Comput Theor Nanosci 2005; 2: 1-25.
[4]
Nagesh RG, Mohammed R, Kumar TN, Gurcharan S. Comparative study of the efficacy of valacyclovir and acyclovir in herpes Zoster. Int J Pharm Biomed Res 2011; 2(2): 119-23.
[5]
Jalonde EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type 1 in cell culture. Eur J Pharm Biopharm 2003; 56: 183-7.
[6]
Francesco P. Valacyclovir polymorphs and a process for the preparation thereof. US 20070021444A1 (2006).
[7]
Ganesh M, Narasimharao CV, Saravana KA, Kamalakannan K, Vinoba M, Mahajan HS. UV spectrophotometric method for the estimation of valacyclovir hcl in tablet dosage. J Chem 2009; 6(3): 814-8.
[8]
Devi KV, Bhosale UV. Formulation and optimization of polymeric nano drug delivery system of Acyclovir. Int J Pharm Tech Res 2009; 1: 644-53.
[9]
Jain SK, Gupta Y, Jain A, Rai K. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 2008; 15: 141-7.
[10]
Habashy RR. Abdel-Naim. Anti-inflammatory effects of jojoba liquid wax in experimental models. Pharmacol Res 2005; 51: 95-105.
[11]
Mohamed LA, Nahla AA, Abdel NBS. Simmondsia Chinensis (Jojoba): A comprehensive pharmacognostic study. J Pharmacog Phytochem 2013; 2: 97-120.
[12]
En-Qin X, Gui-Fang D, Ya-Jun G. GuoHua-Bin L. Biological activities of polyphenols from grapes. Int J Mol Sci 2010; 11: 622-46.
[13]
Garavaglia J, Markoski MM, Oliveira A, Marcadenti A. Grape seed oil compounds: Biological and chemical actions for health. Nutr Metab Insights 2016; 9: 59-64.
[14]
Cao AH, Wang J, Gao HQ, Zhang P, Qiu J. Beneficial clinical effects of grape seed proanthocyanidin extract on the progression of carotid atherosclerotic plaques. J Geriatr Cardiol 2015; 12(4): 417-23.
[15]
Shlomit W. Crystalline forms of valacyclovir hydrochloride. US20050187229A1 (2005).
[16]
Goswami N, Joshi G, Sawant K. Floating microspheres of valacyclovir HCl: Formulation, optimization, characterization, in vitro and in vivo floatability studies. J Pharm Bioallied Sci 2012; 4(1): S8-9.
[17]
Giorgio R, Alberto R. Solid formulations of valacyclovir hydrochloride. WO2007090595A1 (2007).
[18]
Kumar R, Sinha VR. Lipid Nanocarrier: An efficient approach towards ocular delivery of hydrophilic, drug (valacyclovir). AAPS PharmSciTech 2016; 18(3): 884-94.
[19]
Lutker KM, Quiñones R, Xu J, Ramamoorthy A, Matzger AJ. Polymorphs and hydrates of acyclovir. J Pharm Sci 2011; 100(3): 949-63.
[20]
Rice SB, Chan C, Brown SC. Particle size distributions by transmission electron microscopy: An interlaboratory comparison case study. Metrologia 2013; 50(6): 663-78.
[21]
Michael K. The measurement of nanoparticles using photon correlation spectroscopy and avalanche photo diodes. J Nanopart Res 1999; 1(3): 405-9.
[22]
Petersson K, Ilver D, Johansson C. Brownian motion of aggregating nanoparticles studied by photon correlation spectroscopy and measurements of dynamic magnetic properties. Anal Chim Acta 2006; 573: 138-46.
[23]
Lim J, Yeap SP, Che HX, Low SC. Characterization of magnetic nanoparticle by dynamic light scattering. Nanoscale Res Lett 2013; 8(1): 381.
[24]
Jeffrey DC, Anil KP. Zeta potential measurement. Methods Mol Biol 2011; 697: 63-70.
[25]
Deming T. Peptide-Based Materials. Springer Berlin 2012; pp. 129-33.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 1
Year: 2019
Page: [46 - 61]
Pages: 16
DOI: 10.2174/1872211313666190304142129

Article Metrics

PDF: 28
HTML: 3